Applications of Influenza Viral Kinetic Modeling in Drug Development

Current Pharmacology Reports ◽

10.1007/s40495-017-0104-3 ◽

2017 ◽

Vol 3 (5) ◽

pp. 294-300 ◽

Author(s):

Mark Lovern ◽

Suzanne K. Minton ◽

Kashyap Patel ◽

Yuan Xiong ◽

Carl M. Kirkpatrick ◽

...

Keyword(s):

Drug Development ◽

Kinetic Modeling ◽

Download Full-text

Viral kinetic modeling: state of the art

Journal of Pharmacokinetics and Pharmacodynamics ◽

10.1007/s10928-014-9363-3 ◽

2014 ◽

Vol 41 (5) ◽

pp. 431-443 ◽

Author(s):

Laetitia Canini ◽

Alan S. Perelson

Keyword(s):

Kinetic Modeling ◽

State Of The Art ◽

Download Full-text

An Introduction to Kinetic Modeling and Quantification and its Role in Drug Development

Trends on the Role of PET in Drug Development ◽

10.1142/9789814317740_0015 ◽

2012 ◽

pp. 417-453

Author(s):

Antoon T. M. Willemsen ◽

Anne M. J. Paans

Keyword(s):

Drug Development ◽

Kinetic Modeling

Download Full-text

Faculty Opinions recommendation of Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718475782.793496745 ◽

2014 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Triple Therapy ◽

Kinetic Modeling ◽

Pegylated Interferon ◽

Viral Kinetic ◽

Cirrhotic Patients

Download Full-text

Model-Informed Drug Repurposing: Viral Kinetic Modeling to Prioritize Rational Drug Combinations for COVID-19

10.22541/au.159200535.51965254 ◽

2020 ◽

Author(s):

Michael Dodds ◽

Rajesh Krishna ◽

Antonio Gonclaves ◽

Craig Rayner

Keyword(s):

Kinetic Modeling ◽

Drug Repurposing ◽

Drug Combinations ◽

Viral Kinetic ◽

Download Full-text

Viral Kinetic Modeling of Chronic Hepatitis C and B Infection

Lecture Notes in Mathematics - Nonautonomous Dynamical Systems in the Life Sciences ◽

10.1007/978-3-319-03080-7_8 ◽

2013 ◽

pp. 251-268

Author(s):

Eva Herrmann ◽

Yusuke Asai

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Kinetic Modeling ◽

Download Full-text

Understanding silibinin’s modes of action against HCV using viral kinetic modeling

Journal of Hepatology ◽

10.1016/j.jhep.2011.12.012 ◽

2012 ◽

Vol 56 (5) ◽

pp. 1019-1024 ◽

Author(s):

Jeremie Guedj ◽

Harel Dahari ◽

Ralf T. Pohl ◽

Peter Ferenci ◽

Alan S. Perelson

Keyword(s):

Kinetic Modeling ◽

Modes Of Action ◽

Download Full-text

942 VIRAL KINETIC MODELING DURING TREATMENT WITH INTERFERON LAMBDA-1A IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS

Journal of Hepatology ◽

10.1016/s0168-8278(09)60944-2 ◽

2009 ◽

Vol 50 ◽

pp. S342-S343 ◽

Author(s):

M.G. Dodds ◽

D.F. Hausman ◽

D.M. Miller

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Kinetic Modeling ◽

Interferon Lambda ◽

Viral Kinetic ◽

Chronic Hepatitis C Patients

Download Full-text

Opioid Peptide Drug Development: Transport of Opioid Chimeric Peptides Through the Blood-Brain Barrier

PsycEXTRA Dataset ◽

10.1037/e496142006-013 ◽

1992 ◽

Author(s):

William M. Pardridge ◽

Keyword(s):

Drug Development ◽

Blood Brain Barrier ◽

Opioid Peptide ◽

Brain Barrier ◽

Peptide Drug ◽

Blood Brain ◽

Chimeric Peptides

Download Full-text

Joint FDA, NCI Program Aims to Streamline Cancer Drug Development

PsycEXTRA Dataset ◽

10.1037/e542942006-001 ◽

2003 ◽

Keyword(s):

Drug Development ◽

Download Full-text

Pharmacogenomic drug development raises new challenges for drug regulatory agencies

PsycEXTRA Dataset ◽

10.1037/e556272006-011 ◽

2005 ◽

Keyword(s):

Drug Development ◽

Regulatory Agencies ◽

New Challenges ◽

Drug Regulatory Agencies

Download Full-text